86 related articles for article (PubMed ID: 26403215)
1. A novel role for hepatic stellate cells in pathogenesis of visceral leishmaniasis.
Shoukry NH; Fabre T; Gandhi CR
Hepatology; 2016 Feb; 63(2):375-6. PubMed ID: 26403215
[No Abstract] [Full Text] [Related]
2. Hepatic stellate cells regulate liver immunity to visceral leishmaniasis through P110δ-dependent induction and expansion of regulatory T cells in mice.
Khadem F; Gao X; Mou Z; Jia P; Movassagh H; Onyilagha C; Gounni AS; Wright MC; Uzonna JE
Hepatology; 2016 Feb; 63(2):620-32. PubMed ID: 26289140
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic glucocorticoid-induced TNF receptor-mediated amplification of CD4+ T cell responses enhances antiparasitic immunity.
Haque A; Stanley AC; Amante FH; Rivera Fde L; Zhou Y; Kuns RD; Yardley V; Sakaguchi S; Hill GR; Engwerda CR
J Immunol; 2010 Mar; 184(5):2583-92. PubMed ID: 20139272
[TBL] [Abstract][Full Text] [Related]
4. Levels of hepatic Th17 cells and regulatory T cells upregulated by hepatic stellate cells in advanced HBV-related liver fibrosis.
Li X; Su Y; Hua X; Xie C; Liu J; Huang Y; Zhou L; Zhang M; Li X; Gao Z
J Transl Med; 2017 Apr; 15(1):75. PubMed ID: 28399886
[TBL] [Abstract][Full Text] [Related]
5. Regulatory CD4+ T cells modulate the interaction between NK cells and hepatic stellate cells by acting on either cell type.
Langhans B; Alwan AW; Krämer B; Glässner A; Lutz P; Strassburg CP; Nattermann J; Spengler U
J Hepatol; 2015 Feb; 62(2):398-404. PubMed ID: 25195554
[TBL] [Abstract][Full Text] [Related]
6. Immunodetection of hepatic stellate cells in dogs with visceral leishmaniasis.
Marques NC; Mo Reira PRR; Bertolo PHL; Gava FN; Vasconcelos RO
Parasitol Res; 2018 Jun; 117(6):1829-1837. PubMed ID: 29704121
[TBL] [Abstract][Full Text] [Related]
7. Cellular basis of concanavalin A-activated T-cell-mediated suppression of DNA synthesis by PHA-stimulated lymphocytes from patients with Kenyan visceral leishmaniasis.
Koech DK
East Afr Med J; 1983 Dec; 60(12):838-42. PubMed ID: 6233128
[No Abstract] [Full Text] [Related]
8. Immunity, tolerance and autoimmunity in the liver: A comprehensive review.
Doherty DG
J Autoimmun; 2016 Jan; 66():60-75. PubMed ID: 26358406
[TBL] [Abstract][Full Text] [Related]
9. Hepatic immune tolerance induced by hepatic stellate cells.
Hsieh CC; Hung CH; Lu L; Qian S
World J Gastroenterol; 2015 Nov; 21(42):11887-92. PubMed ID: 26576077
[TBL] [Abstract][Full Text] [Related]
10. Hepatic Stellate Cells Inhibit T Cells through Active TGF-β1 from a Cell Surface-Bound Latent TGF-β1/GARP Complex.
Li Y; Kim BG; Qian S; Letterio JJ; Fung JJ; Lu L; Lin F
J Immunol; 2015 Sep; 195(6):2648-56. PubMed ID: 26246140
[TBL] [Abstract][Full Text] [Related]
11. Involvement and interactions of different immune cells and their cytokines in human visceral leishmaniasis.
Bhattacharya P; Ali N
Rev Soc Bras Med Trop; 2013; 46(2):128-34. PubMed ID: 23559342
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological inhibition of p110δ subunit of PI3K confers protection against experimental leishmaniasis.
Khadem F; Jia P; Mou Z; Feiz Barazandeh A; Liu D; Keynan Y; Uzonna JE
J Antimicrob Chemother; 2017 Feb; 72(2):467-477. PubMed ID: 27999013
[TBL] [Abstract][Full Text] [Related]
13. In situ CUTANEOUS CELLULAR IMMUNE RESPONSE IN DOGS NATURALLY AFFECTED BY VISCERAL LEISHMANIASIS.
Rossi CN; Tomokane TY; Batista LF; Marcondes M; Larsson CE; Laurenti MD
Rev Inst Med Trop Sao Paulo; 2016 Jul; 58():48. PubMed ID: 27410908
[TBL] [Abstract][Full Text] [Related]
14. Antigen-specific immunosuppression in visceral leishmaniasis is cell mediated.
Carvalho EM; Bacellar O; Barral A; Badaro R; Johnson WD
J Clin Invest; 1989 Mar; 83(3):860-4. PubMed ID: 2522103
[TBL] [Abstract][Full Text] [Related]
15. [Immunologic complications of visceral leishmaniasis].
Niggli F; Halle F; Seger RA
Monatsschr Kinderheilkd; 1991 Nov; 139(11):772-4. PubMed ID: 1775144
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of allogenic T-cell cytotoxicity by hepatic stellate cell via CD4⁺ CD25⁺ Foxp3⁺ regulatory T cells in vitro.
Wu TJ; Wang YC; Wu TH; Lee CF; Chan KM; Lee WC
Transplant Proc; 2012 May; 44(4):1055-9. PubMed ID: 22564624
[TBL] [Abstract][Full Text] [Related]
17. Visceral leishmaniasis: a disease associated with inability of lymphocytes to activate macrophages to kill leishmania.
Carvalho EM; Bacellar OA; Reed S; Barral A; Rocha H
Braz J Med Biol Res; 1988; 21(1):85-92. PubMed ID: 3179584
[TBL] [Abstract][Full Text] [Related]
18. [Study of cellular immunity in patients with Mediterranean visceral leishmaniasis].
Dunan S; Meller C; Kaplanski S; Mary C; Faugère B; Franck J; Toga I; Farnarier C; Quilici M
Ann Soc Belg Med Trop; 1990 Jun; 70(2):83-97. PubMed ID: 2222009
[TBL] [Abstract][Full Text] [Related]
19. Regulation of immunity during visceral Leishmania infection.
Rodrigues V; Cordeiro-da-Silva A; Laforge M; Silvestre R; Estaquier J
Parasit Vectors; 2016 Mar; 9():118. PubMed ID: 26932389
[TBL] [Abstract][Full Text] [Related]
20. Dynamics of CD62L/CD45RB CD4+ and CD8+ lymphocyte subsets in hepatic and splenic tissues during murine visceral leishmaniasis.
Gomes-Pereira S; Rodrigues OR; Santos-Gomes GM
Immunol Lett; 2004 Aug; 95(1):63-70. PubMed ID: 15325799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
